Relief Therapeutics Holding SA (RLFTF)
OTCMKTS · Delayed Price · Currency is USD
2.940
-0.260 (-8.13%)
Aug 5, 2025, 2:57 PM EDT
Relief Therapeutics Holding Employees
Relief Therapeutics Holding had 31 employees as of December 31, 2024. The number of employees decreased by 18 or -36.73% compared to the previous year.
Employees
31
Change (1Y)
-18
Growth (1Y)
-36.73%
Revenue / Employee
$299,627
Profits / Employee
-$609,400
Market Cap
38.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | -18 | -36.73% |
| Dec 31, 2023 | 49 | -20 | -28.99% |
| Dec 31, 2022 | 69 | 14 | 25.45% |
| Dec 31, 2021 | 55 | 45 | 450.00% |
| Dec 31, 2020 | 10 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Relief Therapeutics Holding News
- 8 days ago - Relief Therapeutics reports proposed business combination with NeuroX - Seeking Alpha
- 8 days ago - Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze - Accesswire
- 6 weeks ago - Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 - Accesswire
- 7 weeks ago - Relief Therapeutics Announces Results of Annual General Meeting - Accesswire
- 2 months ago - Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 - Accesswire
- 2 months ago - Relief Therapeutics Publishes 2025 Annual General Meeting Agenda - Accesswire
- 4 months ago - Relief Therapeutics Holding GAAP EPS of -CHF 1.37, revenue of CHF 9.83B - Seeking Alpha
- 4 months ago - Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update - Accesswire